The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

Founded Year



Acquired | Acquired

Total Raised






About Concentric Medical

Concentric Medical, founded in 1999, is a medical device company committed to opening the pathway to stroke treatment. The company is the first to complete a pivotal trial and receive FDA clearance for a device for the removal of blood clots from patients experiencing an ischemic stroke. The Merci (Mechanical Embolus Removal in Cerebral Ischemia) Retriever is a therapy that removes the clot, restores blood flow and offers hope for ischemic stroke patients with no other options.

Concentric Medical Headquarter Location

301 East Evelyn Avenue

Mountain View, California, 94041,

United States


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Concentric Medical

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Concentric Medical is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,312 items

Companies that received FDA De Novo clearances since 2010. Companies tagged as #FDADeNovos

Concentric Medical Patents

Concentric Medical has filed 29 patents.

The 3 most popular patent topics include:

  • Angiology
  • Bacteriology
  • Cell anatomy
patents chart

Application Date

Grant Date


Related Topics




Angiology, Electromagnetism, Vascular diseases, Actuators, Implants (medicine)


Application Date


Grant Date



Related Topics

Angiology, Electromagnetism, Vascular diseases, Actuators, Implants (medicine)



Latest Concentric Medical News

Neurovascular Access Catheters Market Analysis, Market Trends, Opportunities, and Forecast 2028 | Stryker Corporation, Medtronic Plc, Concentric Medical, Inc., Integer Holdings Corporation | FMI Report

Mar 17, 2021

| FMI Report Future Market Insights (FMI) adopted a multidisciplinary approach during the pandemic-era to focus on the growth and development of the Neurovascular Access Catheters Market. The study features insights on the current growth dynamics and the major revenue reforms prevailing in the market as of 2020 along with the key takeaways over the forecast period. Impact of COVID-19 on the Healthcare Industry The COVID-19 pandemic has caused severe impacts on the global economy at various levels and which can be seen on the Healthcare industry as well. The thriving market of health care research and development is expected to exhibit a steep decline in the sales during the lockdown period owing to the shutdown of the manufacturing units, acute shortage in the supply of raw materials and absence of potential manpower. It can be deduced from the current situations brought about by the pandemic that the production, and supply chain activities have experienced minor hurdles. However, the market is projected to gradually recover post-COVID-19, which will present attractive opportunities for sales across various regions of the world in the following years. The team of analysts at Future Business Insights are focussing on research and market study to produce different Neurovascular Access Catheters Market forecasts and predictions at both national and international levels. They have considered several leads of information pertaining to the industry like market figures and merger estimations to assess and produce reliable and informative insights on the Neurovascular Access Catheters Market. Ask an Analyst @ Key Players   Some of the major neurovascular access catheters manufacturers present across the globe are Stryker Corporation, Medtronic Plc, Concentric Medical, Inc., Integer Holdings Corporation, Biomerics, Penumbra, Inc., Zeus Industrial Products, Inc., DePuy Synthes, RAUMEDIC AG, and others. Segmentation     The global neurovascular access catheters market is classified on the basis of product type, material, design type, end user and region. Based on product type neurovascular access catheters market is segmented into following: Dialysis Catheters Queries Solved What is the size of the overall Neurovascular Access Catheters Market in the Healthcare Industry and its segments? What are the key segments and sub-segments in the market? What are the key drivers, restraints, opportunities, and challenges of the Neurovascular Access Catheters Market in the Healthcare Industry, and how they are expected to impact the market? What are the attractive investment opportunities within the Neurovascular Access Catheters Market in the Healthcare Industry? What is the Neurovascular Access Catheters Market in the Healthcare Industry size at the regional and country-level? What are the key market players focusing on? What are the strategies for growth adopted by the key players in Neurovascular Access Catheters Market in the Healthcare Industry? What are the recent trends in Neurovascular Access Catheters Market in the Healthcare Industry? (M&A, partnerships, new product developments, expansions)? What are the challenges to the Neurovascular Access Catheters Market in the growth of the Healthcare Industry? What are the key market trends impacting the growth of the Neurovascular Access Catheters Market in the Healthcare Industry? Ask for TOC @ Reasons to buy the report We provide authentic and detailed an analysis on various market trends to enable businesses to make informed and beneficial decisions to attain competitive edge over key players. Our analysts provide detailed market segmentation along with meaningful insights and extensive reports that other companies fail to include. The report includes accurate analysis of the market and the current developing trends affecting the growth. FMI speaks to stakeholders across the spectrum, including C-level executives, distributors, product manufacturers, industry experts. This ensures that the data collected is from highly reliable sources. Explore Wide-ranging Coverage of FMI’s Healthcare Market Insights Landscape Cervical Spine System Market FMI’s analysis gives an insight into key market trends, strategies, regional players and various segments on the basis of form, type, application and region. Below-the-knee Implants Market  Find insights into global market scenario and segmentation on the basis of ingredients, application, source and region. Polycythemia Vera Treatment Market FMI’s report highlights parent market trends and strategies in the market with segments and dynamics through the forecast period. About us  Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI  is headquartered in Dubai, the global financial capital, and has delivery centers in the U.S. and India. FMI’s latest  market research reports  and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers. Contact us

  • When was Concentric Medical founded?

    Concentric Medical was founded in 1999.

  • Where is Concentric Medical's headquarters?

    Concentric Medical's headquarters is located at 301 East Evelyn Avenue, Mountain View.

  • What is Concentric Medical's latest funding round?

    Concentric Medical's latest funding round is Acquired.

  • How much did Concentric Medical raise?

    Concentric Medical raised a total of $19.3M.

  • Who are the investors of Concentric Medical?

    Investors of Concentric Medical include Stryker, SV Health Investors, New Enterprise Associates, New Venture Partners, ProQuest Investments and 10 more.

  • Who are Concentric Medical's competitors?

    Competitors of Concentric Medical include MicroTransponder, CoAxia, Cameron Health, Micrus Endovascular, nFocus Neuromedical and 12 more.

You May Also Like

Arbor Surgical Technologies

Arbor Surgical Technologies, Inc. with facilities located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a broad portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery. Arbor Surgical Technologies mission is to simplify cardiac valve surgery through the innovative development of a less invasive, unique implantation system and valves with superior performance and durability. Partnering with physicians, we will improve patient recovery by less invasive techniques and reduced surgery time. Ethical behavior with employees, surgeons, patients and suppliers is the keystone to our success.

NeoChord Logo

NeoChord is a medical technology company engaged in the advancement of beating heart mitral valve repair in patients suffering from mitral valve regurgitation. The company's flagship product, the NeoChord Artificial Chordae Delivery System, received CE market clearance in December 2012.


Atritech has developed the WATCHMAN, an implantable device designed to capture clots that may form in the left atrial appendage of patients with atrial fibrillation, thereby aiming to reduce the risk of stroke and eliminating the need for long-term use of blood thinning medications.

Endologix Logo

Endologix is a developer and manufacturer of minimally invasive treatments for vascular diseases. Endologix is focusing on the development and marketing of its patented technology for the treatment of Abdominal Aortic Aneurysms (AAA). An aneurysm is a weakening of the wall of the aorta, the largest artery of the body. Aortic aneurysm disease is a cause of death in the United States and it is estimated that 1.7 million persons over 55 years of age have an AAA. Each year, physicians diagnose approximately 200,000 people in the United States with AAA. Endologix is currently marketing its Powerlink Delivery System a, one-piece endoluminal stent graft (ELG) used in treating AAA that has significant advantages when compared with marketed stent alternatives. Powerlink has been commercially available in Europe since 1999. FDA approval for the Powerlink AAA stent graft was received on October 29, 2004. The Powerlink superior design is covered by 17 U.S. patents with 361 allowed claims; the technology is designed to overcome shortcomings of first-generation ELGs. The device is for sale in the United States and selected international markets. Endologix is a publicly-held company trading on NASDAQ: ELGX. The company's corporate office is located in Irvine, California.

EndoGastric Solutions

EndoGastric Solutions is developing an endoscopic medical device and procedure that can restore the competency of the anti-reflux barrier, which is distorted in GERD patients and contributes to acid reflux and regurgitation. Designed specifically for performing incisionless reconstructive gastrointestinal procedures, the device is introduced into the body through the mouth, rather than through an abdominal incision.


ValenTx is developing a new therapy to treat patients with obesity and obesity-related metabolic disorders such as type-2 diabetes and hypertension. The company's technology mimics the therapeutic mechanisms of a Roux-en-Y gastric bypass, and does this with a non-surgical, endoluminal bypass device.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.